Bajaj Company Profile
What is the competitive landscape for BAJAJ
BAJAJ has six approved drugs.
Summary for Bajaj
| US Patents: | 0 |
| Tradenames: | 6 |
| Ingredients: | 4 |
| NDAs: | 6 |
Drugs and US Patents for Bajaj
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bajaj | CHLORHEXIDINE GLUCONATE | chlorhexidine gluconate | SOLUTION;TOPICAL | 020111-001 | Sep 11, 1997 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Bajaj | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | SOLUTION;ORAL | 091327-001 | Oct 17, 2011 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Bajaj | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | SOLUTION;ORAL | 075920-001 | Jan 29, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
